Resveratrol Improves Mitochondrial Function
and Protects Against Metabolic Disease by
Activating SIRT1 and PGC-1alpha

This section is compiled by Frank M. Painter, D.C.
Send all comments or additions to:    Frankp@chiro.org

FROM:   Cell 2006 (Dec 15); 127 (6): 1109–1122

Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F,
Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M,
Puigserver P, Auwerx J

Institut de Génétique et de Biologie Moléculaire et Cellulaire,
CNRS / INSERM / ULP, 67404
Illkirch, France

---

Diminished mitochondrial oxidative phosphorylation and aerobic capacity are associated with reduced longevity. We tested whether resveratrol (RSV), which is known to extend lifespan, impacts mitochondrial function and metabolic homeostasis. Treatment of mice with RSV significantly increased their aerobic capacity, as evidenced by their increased running time and consumption of oxygen in muscle fibers. RSV's effects were associated with an induction of genes for oxidative phosphorylation and mitochondrial biogenesis and were largely explained by an RSV-mediated decrease in PGC-1alpha acetylation and an increase in PGC-1alpha activity. This mechanism is consistent with RSV being a known activator of the protein deacetylase, SIRT1, and by the lack of effect of RSV in SIRT1(-/-) MEFs. Importantly, RSV treatment protected mice against diet-induced-obesity and insulin resistance. These pharmacological effects of RSV combined with the association of three Sirt1 SNPs and energy homeostasis in Finnish subjects implicates SIRT1 as a key regulator of energy and metabolic homeostasis.

Return to RESVERATROL

Since 8-31-2008